Monoclonal immunoglobulins and peripheral neuropathy: causative agent or coincidental finding?

Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

Blood advances·2026

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study.

Blood advances·2025

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Blood·2025

Report of Consensus Panel 6 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia.

Seminars in hematology·2025

Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma.

Seminars in hematology·2025

Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

Intravascular large B-Cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen.

Clinical lymphoma·2005

Activity of gallium nitrate in refractory peripheral T-cell lymphoma.

Clinical lymphoma·2005

Non-Hodgkin's lymphoma of the breast: a report of 19 cases and a review of the literature.

Clinical lymphoma·2005

Long-term follow-up high-dose chemotherapy (drug-only program) followed by autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas.

Clinical lymphoma·2005

The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.

Clinical lymphoma·2005

Prognosis of follicular lymphomas.

Clinical lymphoma·2005

The locus coeruleus gateway hypothesis: Noradrenergic integrity as a candidate determinant of amyloid-β clearance efficiency in anti-amyloid immunotherapy for Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026

Pulmonary Light Chain Deposition Disease in a Patient With Chronic Lymphocytic Leukemia.

International journal of surgical pathology·2026

Related Experiment Videos

Monoclonal immunoglobulins and peripheral neuropathy: causative agent or coincidental finding?

Related Concept Videos

Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up.

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study.

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.

Report of Consensus Panel 6 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia.

Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma.

Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials.

Intravascular large B-Cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen.

Activity of gallium nitrate in refractory peripheral T-cell lymphoma.

Non-Hodgkin's lymphoma of the breast: a report of 19 cases and a review of the literature.

Long-term follow-up high-dose chemotherapy (drug-only program) followed by autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas.

The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma.

Prognosis of follicular lymphomas.

The locus coeruleus gateway hypothesis: Noradrenergic integrity as a candidate determinant of amyloid-β clearance efficiency in anti-amyloid immunotherapy for Alzheimer's disease.

Pulmonary Light Chain Deposition Disease in a Patient With Chronic Lymphocytic Leukemia.

Related Experiment Videos

Monoclonal immunoglobulins and peripheral neuropathy: causative agent or coincidental finding?

Related Concept Videos

Related Articles